<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1975694886019755&amp;ev=PageView&amp;noscript=1">
The pandemic was a clear catalyst for the rise of decentralized clinical trials (DCTs). But it may come as a surprise to some that this shift was already gaining momentum in the years prior due to advancements in technology. Telemedicine platforms, electronic data capture[...]
Diversity has always mattered in clinical trials. As the National Institutes of Health (NIH) notes, “people may experience the same disease differently.” With a more diverse pool of clinical trial participants, researchers can better account for these differences and support[...]